Cargando…

Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell

The expeditious progress of Mesenchymal Stromal Cells (MSC) for therapeutic intervention calls for means to compare differences in potency of cell products. The differences may be attributed to innumerable sources including tissue origin, production methods, or even between batches. While the immuno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Stine Bangsgaard, Højgaard, Lisbeth Drozd, Kastrup, Jens, Ekblond, Annette, Follin, Bjarke, Juhl, Morten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791065/ https://www.ncbi.nlm.nih.gov/pubmed/36578497 http://dx.doi.org/10.3389/fimmu.2022.1085312

Ejemplares similares

Increased Paracrine Immunomodulatory Potential of Mesenchymal Stromal Cells in Three-Dimensional Culture
por: Follin, Bjarke, et al.
Publicado: (2016)

Adipose Tissue-Derived Stromal Cells Induce a Highly Trophic Environment While Reducing Maturation of Monocyte-Derived Dendritic Cells
por: Juhl, Morten, et al.
Publicado: (2020)

Adipose-derived stromal cells increase the formation of collagens through paracrine and juxtacrine mechanisms in a fibroblast co-culture model utilizing macromolecular crowding
por: Søndergaard, Rebekka Harary, et al.
Publicado: (2022)

The Initial Cardiac Tissue Response to Cryopreserved Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells in Rats with Chronic Ischemic Cardiomyopathy
por: Follin, Bjarke, et al.
Publicado: (2021)

Identification of a common reference gene pair for qPCR in human mesenchymal stromal cells from different tissue sources treated with VEGF
por: Tratwal, Josefine, et al.
Publicado: (2014)

Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure
por: Qayyum, Abbas Ali, et al.
Publicado: (2023)

Culture expansion of adipose derived stromal cells. A closed automated Quantum Cell Expansion System compared with manual flask-based culture
por: Haack-Sørensen, Mandana, et al.
Publicado: (2016)

GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use
por: Haack-Sørensen, Mandana, et al.
Publicado: (2022)

Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction
por: Follin, Bjarke, et al.
Publicado: (2018)

Cryopreserved Off‐the‐Shelf Allogeneic Adipose‐Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure—A Safety Study
por: Kastrup, Jens, et al.
Publicado: (2017)

Identical effects of VEGF and serum-deprivation on phenotype and function of adipose-derived stromal cells from healthy donors and patients with ischemic heart disease
por: Follin, Bjarke, et al.
Publicado: (2013)

Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review
por: Hoeeg, Cecilie, et al.
Publicado: (2020)

Influence of vascular endothelial growth factor stimulation and serum deprivation on gene activation patterns of human adipose tissue-derived stromal cells
por: Tratwal, Josefine, et al.
Publicado: (2015)

[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) and [(64)Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy
por: Follin, Bjarke, et al.
Publicado: (2023)

An In Vitro Potency Assay for Monitoring the Immunomodulatory Potential of Stromal Cell-Derived Extracellular Vesicles
por: Pachler, Karin, et al.
Publicado: (2017)

Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)](2)) in Induced Myocardial Infarction and Stromal Cell Treatment in Minipigs
por: Rasmussen, Thomas, et al.
Publicado: (2018)

In Vivo MRI Tracking of Mesenchymal Stromal Cells Labeled with Ultrasmall Paramagnetic Iron Oxide Particles after Intramyocardial Transplantation in Patients with Chronic Ischemic Heart Disease
por: Mathiasen, Anders Bruun, et al.
Publicado: (2019)

Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results
por: Qayyum, Abbas Ali, et al.
Publicado: (2019)

Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients
por: Lynggaard, Charlotte Duch, et al.
Publicado: (2022)

Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study
por: Kastrup, Jens, et al.
Publicado: (2017)

Potency Assays for Mesenchymal Stromal Cell Secretome-Based Products for Tissue Regeneration
por: Sagaradze, Georgy, et al.
Publicado: (2023)

Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells
por: Lipat, Ariel Joy, et al.
Publicado: (2022)

Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update
por: Müller, Luise, et al.
Publicado: (2021)

The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells
por: He, Haiping, et al.
Publicado: (2021)

Immunomodulatory Effects of Mesenchymal Stromal Cells in Crohn's Disease
por: Molendijk, Ilse, et al.
Publicado: (2012)

Optimal Labeling Dose, Labeling Time, and Magnetic Resonance Imaging Detection Limits of Ultrasmall Superparamagnetic Iron-Oxide Nanoparticle Labeled Mesenchymal Stromal Cells
por: Mathiasen, Anders Bruun, et al.
Publicado: (2013)

Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled Study
por: Qayyum, Abbas Ali, et al.
Publicado: (2017)

Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction
por: Skibber, Max A., et al.
Publicado: (2022)

The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)

Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
por: Wu, Xiaomo, et al.
Publicado: (2020)

Licensing microgels prolong the immunomodulatory phenotype of mesenchymal stromal cells
por: Patrick, Matthew D., et al.
Publicado: (2022)

Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism
por: Li, Hanyue, et al.
Publicado: (2022)

Tissue-specific Differentiation Potency of Mesenchymal Stromal Cells from Perinatal Tissues
por: Kwon, Ahlm, et al.
Publicado: (2016)

Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativity
por: Galipeau, Jacques
Publicado: (2021)

Dynamics of Ex Vivo Mesenchymal Stromal Cell Potency under Continuous Perfusion
por: Doshi, Aneesha, et al.
Publicado: (2023)

Immunomodulatory Effects of Mesenchymal Stromal Cells Revisited in the Context of Inflammatory Cardiomyopathy
por: Miteva, Kapka, et al.
Publicado: (2013)

Alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy
por: Davis, Mollie S, et al.
Publicado: (2019)

Controlled aggregation enhances immunomodulatory potential of mesenchymal stromal cell aggregates
por: Xie, Angela W., et al.
Publicado: (2021)

Nanotopography reveals metabolites that maintain the immunomodulatory phenotype of mesenchymal stromal cells
por: Ross, Ewan A., et al.
Publicado: (2023)

Applications of Bioinspired Platforms for Enhancing Immunomodulatory Function of Mesenchymal Stromal Cells
por: Kim, Ok-Hyeon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_edgpl9gsk747a5j3ce5302va98